Abstract
The Coronavirus 2019 (COVID-19) is a contagious disease caused by the newly identified severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). The disease has reached pandemic proportions in an extremely short period. The primary cause of this outbreak is through saliva droplets from the infected person to another person. Still, several key causes and limiting factors are unknown, making the intense remedial actions unsubstantial. Our knowledge about how the virus causes damage in the lungs of patients, how the infection raises the immune response (if any) against it, or what is the long-term outcome of patients surviving the devastating complications of the disease is very crucial and has been rising. Researchers are keen to find the epidemiological solution that may protect the people from this pandemic and can aid break the chain. This chapter presents a systematic literature survey for analyzing different aspects of research and also about the clinical studies being carried out on the impact of COVID-19 pandemic on patients ailing from obesity and asthma diseases. This chapter also helps in understanding the association of COVID-19 and its severity with COVID-19-confirmed patients who are already suffering from mild or chronic obesity and asthma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
A. Hancu, F. Mihaltan, Two pandemics coalition: Covid-19 and obesity. Intern. Med. 17, 37–45 (2020)
E. Hernandez-Garduno, Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study. Elsevier Obes. Res. Clin. Pract. 14(4), 375–379 (2020)
K.D. Chhiba et al., Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19. Elsevier Am. Acad. Allergy Asthma Immunol. 146, 307–314 (2020)
C.A. Nogueira-de-Almeida et al., COVID-19 and obesity in childhood and adolescence: A clinical review. Elsevier-Pediatria, 1–13 (2020). https://doi.org/10.1016/j.jped.2020.07.001
F. Sanchis-Gomar et al., Obesity and outcomes in COVID-19: When an epidemic and pandemic collide. Mayo Found. Med. Educ. Res. 95(7), 1445–1453 (2020)
G. Muscogiuri, Commentary: Obesity: The “Achilles heel” for COVID-19? Elsevier Metab. Clin. Exp., 1–2 (2020). https://doi.org/10.1016/j.metabol.2020.154251
H. Kimura et al., Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J. Allergy Clin. Immunol. 146(1), 80–88.e8 (2020)
L. Wang, D. Foer, D.W. Bates, J.A. Boyce, L. Zhou, Risk factors for hospitalization, intensive care and mortality among patients with asthma and COVID-19. Elsevier J. Allergy Clin. Immunol. 146(4), 808–812 (2020)
S. Lovinsky-Desir, D.R. Deshpande, A. De, L. Murray, J.A. Stingone, A. Chan, N. Patel, N. Rai, E. DiMango, J. Milner, M. Kattan, Asthma among hospitalized patients with COVID-19 and related outcomes. J. Allergy Clin. Immunol. 146(5), 1027–1034.e4 (2020)
P. Halvatsiotis, Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity. Elsevier Diabetes Res. Clin. Pract. 166, 108331 (2020)
C. Lubrano et al., Is obesity the missing link between COVID-19 severity and air pollution? Environ. Pollut. 266, 115327 (2020)
M.Q. Almerie et al., The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast. Elsevier Med. Hypotheses 143, 109883 (2020)
E. Garcia-Pachon et al., Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization. Elsevier Respir. Med. 171, 106084 (2020)
J.-S. Yeom, Patterns of viral clearance in the natural course of asymptomatic coronavirus disease 2019 (COVID-19): Comparison with symptomatic nonsevere COVID-19. Elsevier Int. J. Infect. Dis. 99, 279–285 (2020)
Morais-Almeida et al., COVID-19, asthma, and biological therapies: What we need to know. World Allergy Organ. J. 13(5), 100126 (2020)
E. Haroun-Díaz et al., Severe asthma during the COVID-19 pandemic: Clinical observations. Elsevier Am. Acad. Allergy Asthma Immunol. 8(8), 2787–2789 (2020)
Reflecting on World Asthma Day in the era of COVID-19. Lancet Respir. Med. 8, 423 (2020)
Asthma in children during the COVID-19 pandemic: Lessons from lockdown and future directions for management. Lancet Respir. Med. (2020)
J.L. Izquierdo, The impact of COVID-19 on patients with asthma. Eur. Respir. J. (2020). https://doi.org/10.1183/13993003.03142-2020
COVID-19 associated with dramatic decline in ED use by pediatric asthma patients. Med. Express (2020). https://medicalxpress.com/news/2020-06-covid-decline-edpediatric-asthma.html
M. Morais-Almeida, Asthma and the coronavirus disease 2019 pandemic: A literature review. Int. Arch. Allergy Immunol. 181(9), 680–688 (2020)
A. Beurnier et al., Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur. Respir. J. 56, 2001875 (2020)
S. Garg et al., Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, March 1–30, 2020. Morbidity and Mortality Weekly Report
Mahdavinia et al., Asthma prolongs intubation in COVID-19. Elsevier J. Allergy Clin. Immunol. Pract. 8, 2388–2391 (2020)
G.P. Nikolaos et al., Impact of COVID-19 on pediatric asthma: Practice adjustments and disease burden. Elsevier J. Allergy Clin. Immunol. Pract. 8(8), 2592–2599.e3 (2020)
M. Morais-Almeidaa et al., COVID-19 and asthma: To have or not to have T2 inflammation makes a difference? Pulmonology 26, 261–263 (2020)
U. Radzikowska et al., Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. European. J. Allergy Clin. Immunol. 75(11), 2829–2845 (2020)
D. Rastogi, Quantifying the contribution of obesity to incident childhood asthma: It’s about time. J. Am. Acad. Pediatr. 142(6), e20182979 (2018)
A. Simonnet, High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obes. Res. J. 28(7), 1195–1199 (2020)
C. Finelli, Obesity, COVID-19 and immunotherapy: The complex relationship. Immunotherapy (2020). https://doi.org/10.2217/imt-2020-0178
S. Chiappetta, COVID-19 and the role of chronic inflammation in patients with obesity. Int. J. Obes. 44, 1790–1792 (2020)
Y.B. Omar, Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J. Clin. Endocrinol. Metab. 105(8), dgaa346 (2020)
D. Petrakis, Obesity a risk factor for increased COVID 19 prevalence, severity and lethality (Review). Mol. Med. Rep. 22, 9–19 (2020)
N.N. Pettit, Obesity is associated with increased risk for mortality among hospitalized patients with COVID-19. Obesity (2020). https://doi.org/10.1002/oby.22941
H.H. Mohammad, Asthma in COVID-19: An extra chain fitting around the neck? medRxiv (2020)
I. Akoumianakis, T. Filippatos, The renin–angiotensin–aldosterone system as a link between obesity and coronavirus disease 2019 severity. Obes. Rev. 21(9), e13077 (2020)
K. Markos, Association of obesity with disease severity among patients with coronavirus disease 2019. Obes. Res. J. 28(7), 1200–1204 (2020)
A.A.D. Albashir, The potential impacts of obesity on COVID-19. Clin. Med. 20(4), e109–e113 (2020)
J. Wang et al., Overweight and obesity are risks factors of severe illness in patients with COVID-19. Obesity 28(11), 2049–2055 (2020)
A.T. Akenroye, R. Wood, C. Keet, Asthma, biologics, corticosteroids, and COVID-19. Ann. Allergy Asthma Immunol. 125(1), 12–13 (2020)
Sattar et al., Obesity is a risk factor for severe COVID-19 infection: Multiple potential mechanisms. Circulation 142(1), 4–6 (2020)
F. Sanchis-Gomar, C.J. Lavie, M.R. Mehra, Brandon Michael Henry (Mayo Foundation for Medical Education and Research, Giuseppe Lippi, 2020)
S. Kim, H.J. Jin, S.R. Kim, Management of severe asthma during the COVID-19 pandemic in Korea. Allergy, Asthma Immunol. Res. 12(5), 897–901 (2020)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Naik, N.S., Ramalingaswamy, C. (2021). Impact of COVID-19 Pandemic on Obese and Asthma Patients: A Systematic Review. In: Bhatia, S., Dubey, A.K., Chhikara, R., Chaudhary, P., Kumar, A. (eds) Intelligent Healthcare. EAI/Springer Innovations in Communication and Computing. Springer, Cham. https://doi.org/10.1007/978-3-030-67051-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-67051-1_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67050-4
Online ISBN: 978-3-030-67051-1
eBook Packages: EngineeringEngineering (R0)